Home/Elasmogen/Professor Caroline Barelle
PC

Professor Caroline Barelle

Chief Executive Officer

Elasmogen

Elasmogen Pipeline

DrugIndicationPhase
ELN28Hidradenitis Suppurativa (HS)Pre-clinical